For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Pardubice 532 03

0 studies enrolling now · 12 studies all time

What they study most

Acute Coronary Syndrome, Axial Spondyloarthritis, Cardiovascular Diseases, Colorectal Cancer, Diabetes Mellitus, Type 2, Psoriatic Arthritis, Relapsing-Remitting Multiple Sclerosis, Rheumatoid Arthritis, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis Participants — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus — Completed
• A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes — Completed
• A Study in Participants With Type 2 Diabetes Mellitus — Completed
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed